{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:31:55Z","timestamp":1772591515645,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.reprotox.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T12:14:55Z","timestamp":1620130495000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Characterization of pregnancies exposed to St. John\u2019s wort and their outcomes: A claims data analysis"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-448X","authenticated-orcid":false,"given":"Wiebke","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Wentzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Schink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-2923","authenticated-orcid":false,"given":"Ulrike","family":"Haug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2021.04.005_bib0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12906-016-1079-z","article-title":"Safety classification of herbal medicines used in pregnancy in a multinational study","volume":"16","author":"Kennedy","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2021.04.005_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.midw.2013.06.001","article-title":"Women\u2019s use of complementary and alternative medicines during pregnancy: a cross-sectional study","volume":"30","author":"Hall","year":"2014","journal-title":"Midwifery"},{"issue":"5","key":"10.1016\/j.reprotox.2021.04.005_bib0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2009.10.865","article-title":"Herbal use before and during pregnancy","volume":"202","author":"Broussard","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.reprotox.2021.04.005_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/pds.1527","article-title":"Use of herbal drugs during early pregnancy in relation to maternal characteristics and pregnancy outcome","volume":"17","author":"Holst","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.0001-6349.2005.00648.x","article-title":"Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy","volume":"84","author":"Nordeng","year":"2005","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0030","first-page":"85","article-title":"Complementary and alternative medicine therapies for perinatal depression, best practice & research","volume":"28","author":"Deligiannidis","year":"2014","journal-title":"Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.reprotox.2021.04.005_bib0035","first-page":"e268","article-title":"Safety and efficacy of St. John\u2019s wort (hypericum) during pregnancy and lactation","volume":"13","author":"Dugoua","year":"2006","journal-title":"Can. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/bdrb.10050","article-title":"Potential toxicities of herbal therapies in the developing fetus","volume":"68","author":"Jurgens","year":"2003","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2021.04.005_bib0045","series-title":"Arzneimittel in Schwangerschaft und Stillzeit","author":"Schaefer","year":"2012"},{"issue":"4","key":"10.1016\/j.reprotox.2021.04.005_bib0050","first-page":"12","article-title":"St. John\u2019s Wort for major depressive disorder: a systematic review","volume":"5","author":"Maher","year":"2016","journal-title":"Rand Health Q."},{"issue":"S 2","key":"10.1016\/j.reprotox.2021.04.005_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-979522","article-title":"Controlled clinical trials of Hypericum extracts in depressed patients - an overview","volume":"30","author":"Volz","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0060","series-title":"Lehrbuch der Pharmakologie, der klinischen Pharmakologie und Toxikologie. [Mutschler drug reactions. Textbook of pharmacology, clinical pharmacology and toxicology.]","author":"Mutschler","year":"2013"},{"issue":"11","key":"10.1016\/j.reprotox.2021.04.005_bib0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00002018-200427110-00003","article-title":"Drug interactions with St John\u2019s wort : mechanisms and clinical implications","volume":"27","author":"Mannel","year":"2004","journal-title":"Drug Saf."},{"issue":"5","key":"10.1016\/j.reprotox.2021.04.005_bib0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ptr.5050","article-title":"Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions","volume":"28","author":"Russo","year":"2014","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0075","series-title":"Community Herbal Monograph on Hypericum perforatum L., Herba (Well-Established Medicinal Use)","author":"COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC)","year":"2009"},{"issue":"18","key":"10.1016\/j.reprotox.2021.04.005_bib0080","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.280.18.1566","article-title":"St John\u2019s wort during pregnancy","volume":"280","author":"Grush","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.reprotox.2015.10.003","article-title":"Hypericum perforatum use during pregnancy and pregnancy outcome","volume":"58","author":"Kolding","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.reprotox.2009.02.003","article-title":"Evaluating the safety of St. John\u2019s Wort in human pregnancy","volume":"28","author":"Moretti","year":"2009","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2021.04.005_bib0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ctcp.2010.09.002","article-title":"Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome","volume":"17","author":"Nordeng","year":"2011","journal-title":"Complement. Ther. Clin. Pract."},{"issue":"8","key":"10.1016\/j.reprotox.2021.04.005_bib0100","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/bcp.13608","article-title":"Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study","volume":"84","author":"B\u00e9nard-Laribi\u00e8re","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013372","article-title":"Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort","volume":"7","author":"B\u00e9rard","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpsychires.2020.02.023","article-title":"Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies","volume":"124","author":"Biffi","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.reprotox.2021.04.005_bib0115","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pds.4242","article-title":"Use of antidepressant medication in pregnancy and adverse neonatal outcomes: a population-based investigation","volume":"26","author":"Cantarutti","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"21","key":"10.1016\/j.reprotox.2021.04.005_bib0120","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.reprotox.2021.04.005_bib0125","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2021.04.005_bib0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00003088-200645050-00002","article-title":"Hypericum perforatum: a \u2018Modern\u2019 herbal antidepressant","volume":"45","author":"Wurglics","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2021.04.005_bib0135","series-title":"Therapeutic Goods Administration, St John\u2019s Wort (Hypericum perforatum) (all alerts)","year":"2020"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0140","series-title":"St. John\u2019s Wort and Depression: In Depth","author":"N.C.f.C.a.I. Health","year":"2020"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0145","series-title":"Clinical Guideline","article-title":"Depression in adults: recognition and management","author":"National Institute for Health and Care Excellence","year":"2009"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0150","series-title":"Registratie St. Janskruid als geneesmiddel is veiliger voor consumen","author":"C.t.B.v. Geneesmiddelen","year":"2018"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0155","series-title":"Bekanntmachung eines Beschlusses des Gemeinsamen Bundesaussschusses \u00fcber die \u00c4nderung der Arzneimittelrichtlinie (AM-RL): Anlage I (OTC-\u00dcbersicht)","author":"Bundesministerium f\u00fcr Gesundheit","year":"2009"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0160","series-title":"The German Pharmacoepidemiological Research Database (GePaRD)","author":"Leibniz Institute for Prevention Research and Epidemiology - BIPS","year":"2020"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0165","doi-asserted-by":"crossref","unstructured":"U. Haug, T. Schink, German Pharmacoepidemiological Research Database (GePaRD), in: M. Sturkenboom, T. Schink (Eds.), Databases for Pharmacoepidemiological Research, Springer2020 (forthcoming).","DOI":"10.1007\/978-3-030-51455-6_8"},{"issue":"8","key":"10.1016\/j.reprotox.2021.04.005_bib0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/pds.3467","article-title":"Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD)","volume":"22","author":"Mikolajczyk","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"10.1016\/j.reprotox.2021.04.005_bib0175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/pds.4588","article-title":"Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data","volume":"27","author":"Wentzell","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.reprotox.2021.04.005_bib0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fpubh.2020.00350","article-title":"Estimating the beginning of pregnancy in German claims data: development of an algorithm with a focus on the expected delivery date","volume":"8","author":"Schink","year":"2020","journal-title":"Front. Public Health"},{"issue":"3","key":"10.1016\/j.reprotox.2021.04.005_bib0185","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pds.2038","article-title":"Linkage of mother-baby pairs in the german pharmacoepidemiological research database","volume":"20","author":"Garbe","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.reprotox.2021.04.005_bib0190","series-title":"EUROCAT Guide 1.4: Instruction for the Registration of Congenital Anomalies","author":"EUROCAT","year":"2013"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0195","series-title":"Kompendium der Psychiatrischen Pharmakotherapie","article-title":"Antidepressiva","author":"Regen","year":"2019"},{"issue":"4","key":"10.1016\/j.reprotox.2021.04.005_bib0200","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.reprotox.2011.09.004","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations","volume":"32","author":"Sadler","year":"2011","journal-title":"Reprod. Toxicol."},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/tera.1420470609","article-title":"Serotonin and cardiac morphogenesis in the mouse embryo","volume":"47","author":"Yavarone","year":"1993","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","article-title":"Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births","volume":"16","author":"Gao","year":"2018","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00023210-200923060-00004","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"23","author":"Alwan","year":"2009","journal-title":"CNS Drugs"},{"issue":"26","key":"10.1016\/j.reprotox.2021.04.005_bib0220","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.reprotox.2021.04.005_bib0225","first-page":"e4673","article-title":"Risk of congenital heart disease in newborns with prenatal exposure to anti-depressant medications","volume":"11","author":"Desai","year":"2019","journal-title":"Cureus"},{"issue":"26","key":"10.1016\/j.reprotox.2021.04.005_bib0230","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.reprotox.2021.04.005_bib0235","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0004867413492219","article-title":"Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations","volume":"47","author":"Myles","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.reprotox.2021.04.005_bib0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bdra.20627","article-title":"First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies","volume":"88","author":"Wurst","year":"2010","journal-title":"Birth Defects Res. Part A: Clin. Mol. Teratol."},{"key":"10.1016\/j.reprotox.2021.04.005_bib0245","doi-asserted-by":"crossref","first-page":"m237","DOI":"10.1136\/bmj.m237","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"Huybrechts","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0250","series-title":"Prevalence Charts and Tables","author":"European Commission","year":"2021"},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0255","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.contraception.2016.07.010","article-title":"Co-administration of St. John\u2019s wort and hormonal contraceptives: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0260","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clpt.2003.08.009","article-title":"The interaction between St John\u2019s wort and an oral contraceptive","volume":"74","author":"Hall","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2004.11.004","article-title":"Interaction of St. John\u2019s Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding","volume":"71","author":"Murphy","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.reprotox.2021.04.005_bib0270","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/bph.14936","article-title":"Clinical relevance of St. John\u2019s wort drug interactions revisited","volume":"177","author":"Nicolussi","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2021.04.005_bib0275","article-title":"Arzneimittelbehandlung von Schwangeren","volume":"16","author":"Dathe","year":"2020","journal-title":"Dtsch. Arztebl. Int."},{"issue":"3","key":"10.1016\/j.reprotox.2021.04.005_bib0280","first-page":"181","article-title":"Antepartum and postpartum depression: healthy mom, healthy baby","volume":"59","author":"Moses-Kolko","year":"2004","journal-title":"J. Am. Med. Womens Assoc. (1972)"},{"key":"10.1016\/j.reprotox.2021.04.005_bib0285","series-title":"Arzneimittel in Schwangerschaft und Stillzeit","article-title":"Psychische Erkranungen in der Schwangerschaft","author":"N.N","year":"2012"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623821000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:54:57Z","timestamp":1760190897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623821000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":57,"alternative-id":["S0890623821000654"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.04.005","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of pregnancies exposed to St. John\u2019s wort and their outcomes: A claims data analysis","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}